{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:29:40Z","timestamp":1771680580767,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1704177"],"award-info":[{"award-number":["U1704177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8187811"],"award-info":[{"award-number":["8187811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10067-021-05984-1","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T14:04:36Z","timestamp":1636553076000},"page":"1153-1161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Risk factors for progression of interstitial lung disease in Sj\u00f6gren\u2019s syndrome: a single-centered, retrospective study"],"prefix":"10.1007","volume":"41","author":[{"given":"Shi-Hao","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jie","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang-Jin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"5984_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA (2018) Primary Sjogren\u2019s syndrome. N Engl J Med 378:931\u2013939. https:\/\/doi.org\/10.1056\/NEJMcp1702514","journal-title":"N Engl J Med"},{"key":"5984_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sjogren\u2019s syndrome. Eur Respir Rev 25:110\u2013123. https:\/\/doi.org\/10.1183\/16000617.0011-2016","journal-title":"Eur Respir Rev"},{"key":"5984_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-030-63046-1_12","volume":"1303","author":"RA Peredo","year":"2021","unstructured":"Peredo RA, Beegle S (2021) Sjogren\u2019s syndrome and pulmonary disease. Adv Exp Med Biol 1303:193\u2013207. https:\/\/doi.org\/10.1007\/978-3-030-63046-1_12","journal-title":"Adv Exp Med Biol"},{"key":"5984_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.reuma.2015.09.003","volume":"12","author":"D Reina","year":"2016","unstructured":"Reina D, Roig Vilaseca D, Torrente-Segarra V et al (2016) Sjogren\u2019s syndrome-associated interstitial lung disease: a multicenter study. Reumatol Clin 12:201\u2013205. https:\/\/doi.org\/10.1016\/j.reuma.2015.09.003","journal-title":"Reumatol Clin"},{"key":"5984_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10067-019-04753-5","volume":"39","author":"R Zhao","year":"2020","unstructured":"Zhao R, Wang Y, Zhou W et al (2020) Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjogren\u2019s syndrome. Clin Rheumatol 39:483\u2013489. https:\/\/doi.org\/10.1007\/s10067-019-04753-5","journal-title":"Clin Rheumatol"},{"key":"5984_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011003","volume":"97","author":"H Gao","year":"2018","unstructured":"Gao H, Zhang XW, He J et al (2018) Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjogren syndrome patients: a case-control study. Medicine (Baltimore) 97:e11003. https:\/\/doi.org\/10.1097\/MD.0000000000011003","journal-title":"Medicine (Baltimore)"},{"key":"5984_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105895","volume":"163","author":"C Buvry","year":"2020","unstructured":"Buvry C, Cassagnes L, Tekath M et al (2020) Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjogren syndrome. Respir Med 163:105895. https:\/\/doi.org\/10.1016\/j.rmed.2020.105895","journal-title":"Respir Med"},{"issue":"Suppl 126","key":"5984_CR8","first-page":"291","volume":"38","author":"F Luppi","year":"2020","unstructured":"Luppi F, Sebastiani M, Silva M et al (2020) Interstitial lung disease in Sjogren\u2019s syndrome: a clinical review. Clin Exp Rheumatol 38(Suppl 126):291\u2013300","journal-title":"Clin Exp Rheumatol"},{"key":"5984_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/1756-185X.12583","volume":"18","author":"X Li","year":"2015","unstructured":"Li X, Xu B, Ma Y et al (2015) Clinical and laboratory profiles of primary Sjogren\u2019s syndrome in a Chinese population: a retrospective analysis of 315 patients. Int J Rheum Dis 18:439\u2013446. https:\/\/doi.org\/10.1111\/1756-185X.12583","journal-title":"Int J Rheum Dis"},{"key":"5984_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","volume":"16","author":"F Roca","year":"2017","unstructured":"Roca F, Dominique S, Schmidt J et al (2017) Interstitial lung disease in primary Sjogren\u2019s syndrome. Autoimmun Rev 16:48\u201354. https:\/\/doi.org\/10.1016\/j.autrev.2016.09.017","journal-title":"Autoimmun Rev"},{"key":"5984_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.105811","volume":"159","author":"Y Kamiya","year":"2019","unstructured":"Kamiya Y, Fujisawa T, Kono M et al (2019) Prognostic factors for primary Sjogren\u2019s syndrome-associated interstitial lung diseases. Respir Med 159:105811. https:\/\/doi.org\/10.1016\/j.rmed.2019.105811","journal-title":"Respir Med"},{"key":"5984_CR12","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s10067-019-04906-6","volume":"39","author":"T Zhang","year":"2020","unstructured":"Zhang T, Yuan F, Xu L, Sun W, Liu L, Xue J (2020) Characteristics of patients with primary Sjogren\u2019s syndrome associated interstitial lung disease and relevant features of disease progression. Clin Rheumatol 39:1561\u20131568. https:\/\/doi.org\/10.1007\/s10067-019-04906-6","journal-title":"Clin Rheumatol"},{"key":"5984_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558. https:\/\/doi.org\/10.1136\/ard.61.6.554","journal-title":"Ann Rheum Dis"},{"key":"5984_CR14","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s10067-018-4289-6","volume":"37","author":"X Dong","year":"2018","unstructured":"Dong X, Zhou J, Guo X et al (2018) A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjogren\u2019s syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol 37:2981\u20132988. https:\/\/doi.org\/10.1007\/s10067-018-4289-6","journal-title":"Clin Rheumatol"},{"key":"5984_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073774","volume":"8","author":"Y Enomoto","year":"2013","unstructured":"Enomoto Y, Takemura T, Hagiwara E et al (2013) Prognostic factors in interstitial lung disease associated with primary Sjogren\u2019s syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS ONE 8:e73774. https:\/\/doi.org\/10.1371\/journal.pone.0073774","journal-title":"PLoS ONE"},{"key":"5984_CR16","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.200611-1685OC","volume":"177","author":"WD Travis","year":"2008","unstructured":"Travis WD, Hunninghake G, King TE Jr et al (2008) Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 177:1338\u20131347. https:\/\/doi.org\/10.1164\/rccm.200611-1685OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5984_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ et al (2011) An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788\u2013824. https:\/\/doi.org\/10.1164\/rccm.2009-040GL","journal-title":"Am J Respir Crit Care Med"},{"key":"5984_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3389\/fimmu.2019.01327","volume":"10","author":"S Gupta","year":"2019","unstructured":"Gupta S, Ferrada MA, Hasni SA (2019) Pulmonary manifestations of primary Sjogren\u2019s syndrome: underlying immunological mechanisms, clinical presentation, and management. Front Immunol 10:1327. https:\/\/doi.org\/10.3389\/fimmu.2019.01327","journal-title":"Front Immunol"},{"key":"5984_CR19","doi-asserted-by":"publisher","first-page":"102447","DOI":"10.1016\/j.autrev.2019.102447","volume":"19","author":"G Sambataro","year":"2020","unstructured":"Sambataro G, Ferro F, Orlandi M et al (2020) Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjgren\u2019s syndrome: a systematic review from the Italian Society of Rheumatology. Autoimmun Rev 19:102447. https:\/\/doi.org\/10.1016\/j.autrev.2019.102447","journal-title":"Autoimmun Rev"},{"key":"5984_CR20","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/art.40574","volume":"70","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V (2018) The lung in rheumatoid arthritis: focus on interstitial lung disease. Arthritis Rheumatol 70:1544\u20131554. https:\/\/doi.org\/10.1002\/art.40574","journal-title":"Arthritis Rheumatol"},{"key":"5984_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","volume":"201","author":"D Khanna","year":"2020","unstructured":"Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J (2020) Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med 201:650\u2013660. https:\/\/doi.org\/10.1164\/rccm.201903-0563CI","journal-title":"Am J Respir Crit Care Med"},{"key":"5984_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0039-1688448","volume":"40","author":"A Chung","year":"2019","unstructured":"Chung A, Wilgus ML, Fishbein G, Lynch JP 3rd (2019) Pulmonary and bronchiolar involvement in Sjogren\u2019s syndrome. Semin Respir Crit Care Med 40:235\u2013254. https:\/\/doi.org\/10.1055\/s-0039-1688448","journal-title":"Semin Respir Crit Care Med"},{"key":"5984_CR23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10067-018-4382-x","volume":"38","author":"Q Fu","year":"2019","unstructured":"Fu Q, Wang L, Li L, Li Y, Liu R, Zheng Y (2019) Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population. Clin Rheumatol 38:1109\u20131116. https:\/\/doi.org\/10.1007\/s10067-018-4382-x","journal-title":"Clin Rheumatol"},{"key":"5984_CR24","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.3899\/jrheum.141182","volume":"42","author":"D Khanna","year":"2015","unstructured":"Khanna D, Mittoo S, Aggarwal R et al (2015) Connective tissue disease-associated interstitial lung diseases (CTD-ILD) - report from OMERACT CTD-ILD Working Group. J Rheumatol 42:2168\u20132171. https:\/\/doi.org\/10.3899\/jrheum.141182","journal-title":"J Rheumatol"},{"key":"5984_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/00005382-200110000-00009","volume":"16","author":"M Uffmann","year":"2001","unstructured":"Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ (2001) Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging 16:282\u2013289. https:\/\/doi.org\/10.1097\/00005382-200110000-00009","journal-title":"J Thorac Imaging"},{"key":"5984_CR26","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381:1718\u20131727. https:\/\/doi.org\/10.1056\/NEJMoa1908681","journal-title":"N Engl J Med"},{"key":"5984_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu W, Guo L, Fu Y et al (2021) Interstitial lung disease in Anti-MDA5 positive dermatomyositis. Clin Rev Allergy Immunol 60:293\u2013304. https:\/\/doi.org\/10.1007\/s12016-020-08822-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"5984_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1164\/rccm.201011-1790OC","volume":"184","author":"RM du Bois","year":"2011","unstructured":"du Bois RM, Weycker D, Albera C et al (2011) Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184:459\u2013466. https:\/\/doi.org\/10.1164\/rccm.201011-1790OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5984_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40248-019-0179-2","volume":"14","author":"N Ciancio","year":"2019","unstructured":"Ciancio N, Pavone M, Torrisi SE et al (2019) Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases. Multidiscip Respir Med 14:17. https:\/\/doi.org\/10.1186\/s40248-019-0179-2","journal-title":"Multidiscip Respir Med"},{"key":"5984_CR30","first-page":"1254","volume":"29","author":"K Kusume","year":"1991","unstructured":"Kusume K (1991) Lung injury in idiopathic pulmonary fibrosis and measurement of immunoreactive neutrophil elastase and alpha 1-protease inhibitor in blood. Nihon Kyobu Shikkan Gakkai Zasshi 29:1254\u20131260","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"5984_CR31","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10067-019-04846-1","volume":"39","author":"L Li","year":"2020","unstructured":"Li L, Liu R, Zhang Y et al (2020) A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 39:1457\u20131470. https:\/\/doi.org\/10.1007\/s10067-019-04846-1","journal-title":"Clin Rheumatol"},{"key":"5984_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035420","volume":"10","author":"H Kamiya","year":"2020","unstructured":"Kamiya H, Panlaqui OM (2020) Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis. BMJ Open 10:e035420. https:\/\/doi.org\/10.1136\/bmjopen-2019-035420","journal-title":"BMJ Open"},{"key":"5984_CR33","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s10067-017-3601-1","volume":"36","author":"A Manfredi","year":"2017","unstructured":"Manfredi A, Sebastiani M, Cerri S et al (2017) Prevalence and characterization of non-sicca onset primary Sjogren syndrome with interstitial lung involvement. Clin Rheumatol 36:1261\u20131268. https:\/\/doi.org\/10.1007\/s10067-017-3601-1","journal-title":"Clin Rheumatol"},{"key":"5984_CR34","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/1756-185X.13334","volume":"21","author":"H Gao","year":"2018","unstructured":"Gao H, Zou YD, Zhang XW et al (2018) Interstitial lung disease in non-sicca onset primary Sjogren\u2019s syndrome: a large-scale case-control study. Int J Rheum Dis 21:1423\u20131429. https:\/\/doi.org\/10.1111\/1756-185X.13334","journal-title":"Int J Rheum Dis"},{"key":"5984_CR35","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1183\/09031936.00131813","volume":"43","author":"RM du Bois","year":"2014","unstructured":"du Bois RM, Albera C, Bradford WZ et al (2014) 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J 43:1421\u20131429. https:\/\/doi.org\/10.1183\/09031936.00131813","journal-title":"Eur Respir J"},{"key":"5984_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ijcard.2016.03.084","volume":"212","author":"E Vandecasteele","year":"2016","unstructured":"Vandecasteele E, De Pauw M, De Keyser F et al (2016) Six-minute walk test in systemic sclerosis: a systematic review and meta-analysis. Int J Cardiol 212:265\u2013273. https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.084","journal-title":"Int J Cardiol"},{"key":"5984_CR37","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.ejim.2017.05.018","volume":"43","author":"P Santus","year":"2017","unstructured":"Santus P, Radovanovic D, Frassanito F, Cristiano A, Rizzi M (2017) Is the six-minute walk test useful or useless in systemic sclerosis? Eur J Intern Med 43:e37\u2013e39. https:\/\/doi.org\/10.1016\/j.ejim.2017.05.018","journal-title":"Eur J Intern Med"},{"key":"5984_CR38","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3899\/jrheum.170994","volume":"45","author":"G Pugnet","year":"2018","unstructured":"Pugnet G, Marjanovic Z, Deligny C et al (2018) Reproducibility and utility of the 6-minute walk test in systemic sclerosis. J Rheumatol 45:1273\u20131280. https:\/\/doi.org\/10.3899\/jrheum.170994","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05984-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05984-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05984-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T16:36:36Z","timestamp":1647016596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05984-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5984"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05984-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"31 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University. Written informed consent was not required owing to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}